Thursday, 22 May 2025 | 16:30 - 16:40
A novel, non-invasive approach to treat canine cancer - Annelies Bogaerts, Benno Therapeutics
Format:In-person
With strong proof-of-concept data in canine bladder cancer, Benno Therapeutics is advancing veterinary oncology with a first-in-class immunotherapy targeting the tumor vasculature, that has the potential to revolutionize cancer treatment in pets.